Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Explore Which Indices Move This Week and the key drivers behind recent changes. The section offers concise observations to help readers interpret market dynamics.
26,181 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
JPMorgan has begun a pilot that compares junior bankers' self-reported hours to computer activity, including keystrok...
Progressive lawmakers unveiled a bill to halt new data centers for two years while federal safeguards for energy, lab...
As Alabama lawmakers move toward compromise on utility bills, investors argue that southern company risk looks more m...
As markets wobble in 2026, retirees face hidden costs from withdrawal sequencing and tax drag that quietly erode life...
When a legendary brand names a new leader, investors lean in. Disney's CEO, Josh D'Amaro, arrives with a plan to shar...
This in-depth look breaks down Unity's Q1 2026 earnings call, outlining revenue drivers, profitability, and what the ...
In a volatile world, a few dominant companies offer steadier upside. This article spotlights two stocks with monster ...
May often stirs market chatter about seasonal weakness, yet patient investors can find lasting value. Here are two gr...
This detailed microsoft stock analysis: final verdict breaks down the cloud, AI, and cash flow that power MSFT. Learn...
Rare-earths power modern magnets critical to tech, energy, and defense. This guide shows how to identify the best rar...
The (feam) 2026 earnings call offers more than numbers. It reveals management’s strategy, how FEAM is navigating cost...